Enrollment is critical to a trial, and site performance is a major – if not the most important – driver of that. We’ve always known that our full stack system enables sites to increase efficiency and enhance data quality, but do sites who use CRIO actually enroll more? We now have data to prove that...
Running a Site
With the recent push toward Decentralized Clinical Trials (DCTs), many sponsors are adopting eConsent. eConsent allows patients to consent electronically, whether in clinic or remotely, from the convenience of their home. eConsent offers sponsors, CROs, investigators and patients these benefits: Reduce errors by ensuring completion of all fields Automated audit trails ensure accuracy of date-times...
Running a Study
Mary Brenner, MSN MArch RN, is CRIO’s Study Design Manager and brings deep-rooted expertise as a registered nurse to CRIO’s in-house study design team. In this quick Q&A, Mary shares the benefits of good study design for sponsors and sites, the downstream effects of standardized study designs, and gives tips for designing it on your...
Running a Site
Reflections on the Summit The 2021 Global Site Solutions Summit, hosted by the Society for Clinical Research Sites, was an amazing event. The first in-person event that our company has attended in 18 months, the Summit provided an opportunity for CRIO to meet new people and reconnect with clients and friends alike. Post-Pandemic Trends, Here...
CRIO Company News
CRIO has been highlighted among the top solutions that help researchers track application deadlines, project milestones, and participant demographics. BOSTON, MA – August 24, 2021 – Clinical Research IO (CRIO), a Boston-based company working to transform the clinical research industry with the latest in the cloud and SaaS technology, has been named among the best...
Running a Site
The staying power of technology after the pandemic The clinical trials industry has historically been slow to adopt innovation, but 2020 was a catalyst for transformation. Spurred on by the need for business continuity during the pandemic, sites and sponsors worldwide were highly motivated to reconsider business as usual, and many have adopted an array...
Achieving representative enrollment – meaning diversity in race, age, gender and socioeconomic status – in clinical trials is essential to the development of cutting-edge therapies for the general population. Despite being recognized as a need within the industry, it has proven to be a longstanding challenge. According to the 2019 ‘Drugs Trials Snapshots’ report released...
Running a Site
If advertising your clinical trial for patient recruitment is tough for your research site, you aren’t alone. According to the National Institute of Health, among U.S. investigators participating in a clinical trial, “75% of investigators fail to enroll the target number of subjects.” This issue could spell trouble for you, translating to less revenue and...
